{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:11:49Z","timestamp":1790244709288,"version":"4.1.0"},"reference-count":112,"publisher":"National Institute for Health and Care Research","issue":"12","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["10\/94\/02"],"award-info":[{"award-number":["10\/94\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title><jats:p>Unprovoked first venous thromboembolism (VTE) is defined as VTE in the absence of a temporary provoking factor such as surgery, immobility and other temporary factors. Recurrent VTE in unprovoked patients is highly prevalent, but easily preventable with oral anticoagulant (OAC) therapy. The unprovoked population is highly heterogeneous in terms of risk of recurrent VTE.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-2\"><jats:title>Objectives<\/jats:title><jats:p>The first aim of the project is to review existing prognostic models which stratify individuals by their recurrence risk, therefore potentially allowing tailored treatment strategies. The second aim is to enhance the existing research in this field, by developing and externally validating a new prognostic model for individual risk prediction, using a pooled database containing individual patient data (IPD) from several studies. The final aim is to assess the economic cost-effectiveness of the proposed prognostic model if it is used as a decision rule for resuming OAC therapy, compared with current standard treatment strategies.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-3\"><jats:title>Methods<\/jats:title><jats:p>Standard systematic review methodology was used to identify relevant prognostic model development, validation and cost-effectiveness studies. Bibliographic databases (including MEDLINE, EMBASE and The Cochrane Library) were searched using terms relating to the clinical area and prognosis. Reviewing was undertaken by two reviewers independently using pre-defined criteria. Included full-text articles were data extracted and quality assessed. Critical appraisal of included full texts was undertaken and comparisons made of model performance. A prognostic model was developed using IPD from the pooled database of seven trials. A novel internal\u2013external cross-validation (IECV) approach was used to develop and validate a prognostic model, with external validation undertaken in each of the trials iteratively. Given good performance in the IECV approach, a final model was developed using all trials data. A Markov patient-level simulation was used to consider the economic cost-effectiveness of using a decision rule (based on the prognostic model) to decide on resumption of OAC therapy (or not).<\/jats:p><\/jats:sec><jats:sec id=\"abs1-4\"><jats:title>Results<\/jats:title><jats:p>Three full-text articles were identified by the systematic review. Critical appraisal identified methodological and applicability issues; in particular, all three existing models did not have external validation. To address this, new prognostic models were sought with external validation. Two potential models were considered: one for use at cessation of therapy (pre D-dimer), and one for use after cessation of therapy (post D-dimer). Model performance measured in the external validation trials showed strong calibration performance for both models. The post D-dimer model performed substantially better in terms of discrimination (<jats:italic>c<\/jats:italic>\u2009=\u20090.69), better separating high- and low-risk patients. The economic evaluation identified that a decision rule based on the final post D-dimer model may be cost-effective for patients with predicted risk of recurrence of over 8% annually; this suggests continued therapy for patients with predicted risks \u2265\u20098% and cessation of therapy otherwise.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-5\"><jats:title>Conclusions<\/jats:title><jats:p>The post D-dimer model performed strongly and could be useful to predict individuals\u2019 risk of recurrence at any time up to 2\u20133 years, thereby aiding patient counselling and treatment decisions. A decision rule using this model may be cost-effective for informing clinical judgement and patient opinion in treatment decisions. Further research may investigate new predictors to enhance model performance and aim to further externally validate to confirm performance in new, non-trial populations. Finally, it is essential that further research is conducted to develop a model predicting bleeding risk on therapy, to manage the balance between the risks of recurrence and bleeding.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-6\"><jats:title>Study registration<\/jats:title><jats:p>This study is registered as PROSPERO CRD42013003494.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-7\"><jats:title>Funding<\/jats:title><jats:p>The National Institute for Health Research Health Technology Assessment programme.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta20120","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T13:09:51Z","timestamp":1455714591000},"page":"1-190","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation"],"prefix":"10.3310","volume":"20","author":[{"given":"Joie","family":"Ensor","sequence":"first","affiliation":[{"name":"Public Health, Epidemiology and Biostatistics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"},{"name":"Research Institute of Primary Care and Health Sciences, Keele University, Staffordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D","family":"Riley","sequence":"additional","affiliation":[{"name":"Public Health, Epidemiology and Biostatistics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"},{"name":"Research Institute of Primary Care and Health Sciences, Keele University, Staffordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Jowett","sequence":"additional","affiliation":[{"name":"Health Economics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Monahan","sequence":"additional","affiliation":[{"name":"Health Economics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym IE","family":"Snell","sequence":"additional","affiliation":[{"name":"Public Health, Epidemiology and Biostatistics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bayliss","sequence":"additional","affiliation":[{"name":"Public Health, Epidemiology and Biostatistics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moore","sequence":"additional","affiliation":[{"name":"Public Health, Epidemiology and Biostatistics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fitzmaurice","sequence":"additional","affiliation":[{"name":"Primary Care Clinical Sciences, School of Health and Population Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PIT-STOP collaborative group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2016,2]]},"reference":[{"key":"key20160216115237868_ref1-bib1","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"key20160216115237868_ref1-bib2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation"},{"key":"key20160216115237868_ref1-bib3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2141.2011.08753.x","article-title":"Guidelines on oral anticoagulation with warfarin \u2013 fourth edition","volume":"154","author":"Keeling","year":"2011","journal-title":"Br J Haematol"},{"key":"key20160216115237868_ref1-bib4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amjmed.2009.09.011","article-title":"Appropriate use of D-dimer in hospital patients","volume":"123","author":"Thachil","year":"2010","journal-title":"Am J Med"},{"key":"key20160216115237868_ref1-bib5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1538-7836.2006.01795.x","article-title":"Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months","volume":"4","author":"Schulman","year":"2006","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib6","doi-asserted-by":"publisher","first-page":"d813","DOI":"10.1136\/bmj.d813","article-title":"Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis","volume":"342","author":"Douketis","year":"2011","journal-title":"BMJ"},{"key":"key20160216115237868_ref1-bib7","unstructured":"Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, et al. Are Men at Higher Risk for Disease Recurrence than Women. 21st International Congress on Thrombosis \u2013 The Start of a New Era \u2013 Antithrombotic Agents, Milan, Italy, 6\u20139 July 2010."},{"key":"key20160216115237868_ref1-bib8","volume-title":"Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism","author":"Rodger"},{"key":"key20160216115237868_ref1-bib9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"key":"key20160216115237868_ref1-bib10","doi-asserted-by":"publisher","first-page":"e1001380","DOI":"10.1371\/journal.pmed.1001380","article-title":"Prognosis Research Strategy (PROGRESS) 2: prognostic factor research","volume":"10","author":"Riley","year":"2013","journal-title":"PLOS Med"},{"key":"key20160216115237868_ref1-bib11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7326\/0003-4819-153-8-201010190-00009","article-title":"Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism","volume":"153","author":"Douketis","year":"2010","journal-title":"Ann Intern Med"},{"key":"key20160216115237868_ref1-bib12","doi-asserted-by":"publisher","first-page":"d8312","DOI":"10.1136\/bmj.d8312","article-title":"Clinical prediction rules","volume":"344","author":"Adams","year":"2012","journal-title":"BMJ"},{"key":"key20160216115237868_ref1-bib13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/2046-4053-2-91","article-title":"Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE","volume":"2","author":"Ensor","year":"2013","journal-title":"Syst Rev"},{"key":"key20160216115237868_ref1-bib14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key20160216115237868_ref1-bib15","volume-title":"PROBAST Project Summary","year":"2014"},{"key":"key20160216115237868_ref1-bib16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","journal-title":"Control Clin Trials"},{"key":"key20160216115237868_ref1-bib17","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"key20160216115237868_ref1-bib18","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis Research Strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLOS Med"},{"key":"key20160216115237868_ref1-bib19","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","article-title":"Prognosis and prognostic research: validating a prognostic model","volume":"338","author":"Altman","year":"2009","journal-title":"BMJ"},{"key":"key20160216115237868_ref1-bib20","first-page":"717","article-title":"Risk factors of the recurrence of venous thromboembolism","volume":"57","author":"Emmerich","year":"2007","journal-title":"Revue du Praticien"},{"key":"key20160216115237868_ref1-bib21","first-page":"709","article-title":"Pulmonary embolism. Significant diagnostic and therapeutic advances","volume":"57","author":"Meyer","year":"2007","journal-title":"Revue du Praticien"},{"key":"key20160216115237868_ref1-bib22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1134-2072(08)72238-2","article-title":"Low risk of pulmonary embolism after discontinuing anticoagulant treatment for deep venous thrombosis?","volume":"15","author":"Ramalle-Gomara","year":"2008","journal-title":"FMC Formacion Medica Continuada en Atencion Primaria"},{"key":"key20160216115237868_ref1-bib23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0873-2159(15)30148-3","article-title":"Update in pulmonary thromboembolic disease","volume":"15","author":"Man","year":"2009","journal-title":"Revista Portuguesa de Pneumologia"},{"key":"key20160216115237868_ref1-bib24","first-page":"30","article-title":"Risk factors for venous thromboembolic complications and their association with D-dimer level","volume":"82","author":"Vorob\u2019eva","year":"2010","journal-title":"Ter Arkh"},{"key":"key20160216115237868_ref1-bib25","first-page":"52","article-title":"Independent predictors of deep vein thrombosis (results of prospective 18 months study)","volume":"50","author":"Vorob\u2019eva","year":"2010","journal-title":"Kardiologiia"},{"key":"key20160216115237868_ref1-bib26","volume-title":"Cost-Effectiveness of Tailoring Anticoagulant Therapy by a VTE Recurrence Prediction Model in Patients with Venous Thrombo-Embolism as Compared to Care-As-Usual: The VISTA Study","year":"2013"},{"key":"key20160216115237868_ref1-bib27","doi-asserted-by":"crossref","unstructured":"Rodger M, Kovacs CMJ, Kahn S, Wells P, Anderson D, Gregoire LG, et al. Extended Follow-Up of the Multi-Center Multi-National Prospective Cohort Study that Derived the \u2018Men Continue and HERDOO2\u2019 Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (OAC) 5\u20137 Months After Treatment for Unprovoked Venous Thromboembolism (VTE). 51st Annual Meeting of the American Society of Hematology, New Orleans, LA, 5\u20138 December 2009.","DOI":"10.1182\/blood.V114.22.451.451"},{"key":"key20160216115237868_ref1-bib28","unstructured":"Rodger MA, Rodger M, Kovacs M, Le Gal G, Kahn S, Anderson D, et al. Extended Follow-Up of the Multi-Center Prospective Cohort that Derived the \u2018Men Continue and HERDOO2\u2019 Clinical Decision Rule Identifying Low Risk Unprovoked Patients. 23rd Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting, Kyoto, Japan 23\u201328 July 2011."},{"key":"key20160216115237868_ref1-bib29","volume-title":"The Development and Evaluation of a Prognostic Model and Clinical Decision Rule to Help Decide on Cessation of Anticoagulant Therapy in Patients with Idiopathic Venous Thromboembolism (VTE)","year":"2014"},{"key":"key20160216115237868_ref1-bib30","doi-asserted-by":"crossref","unstructured":"Eichinger S, Heinze G, Kyrle PA. D-Dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model. 24th Congress of the International Society on Thrombosis and Haemostasis, Amsterdam, Netherlands, 29 June\u20134 July 2013. http:\/\/dx.doi.org\/10.1161\/jaha.113.000467","DOI":"10.1161\/JAHA.113.000467"},{"key":"key20160216115237868_ref1-bib31","unstructured":"Eichinger S, Heinze G, Kyrle PA. D-dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model. 55th Annual Meeting of the American Society of Hematology, New Orleans, LA, 7\u201310 December 2013."},{"key":"key20160216115237868_ref1-bib32","unstructured":"Eichinger S, Heinze G, Kyrle PA. D-dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model. 16th Tri-Country Congress of the Austrian, German and Swiss Society of Angiology, Graz Austria, 15\u201318 September 2013."},{"key":"key20160216115237868_ref1-bib33","unstructured":"Lazo-Langner A, Abdulrehman J, Taylor EJ, Sharma S, Kovacs MJ. The Use of the REVERSE Study Clinical Prediction Rule for Risk Stratification After Initial Anticoagulation Results in Decreased Recurrences in Patients with Idiopathic Venous Thromboembolism. 24th Congress of the International Society on Thrombosis and Haemostasis, Amsterdam, Netherlands, 29 June\u20134 July 2013."},{"key":"key20160216115237868_ref1-bib34","unstructured":"Marcucci M, Eichinger S, Iorio A, Douketis JD, Tosetto A, Baglin TPT, et al. External Validation and Updating of the Vienna Prediction Model for Recurrent Venous Thromboembolism Using a Pooled Individual Patient Data Database. 24th Congress of the International Society on Thrombosis and Haemostasis, Amsterdam. Netherlands, 29 June\u20134 July 2013."},{"key":"key20160216115237868_ref1-bib35","unstructured":"Rodger M, Kovacs M, Le GG, Anderson D, Righini M, Beaudoin T. The REVERSE I and II Studies: Impact of Using Men Continue and HERDOO2 Clinical Decision Rule to Guide Anticoagulant Therapy in Patients with First Unprovoked Venous Thromboembolism. 24th Congress of the International Society on Thrombosis and Haemostasis, Amsterdam, Netherlands, 29 June\u20134 July 2013."},{"key":"key20160216115237868_ref1-bib36","unstructured":"Eichinger S, Heinze G, Kyrle PA. Risk Assessment Model to Predict Recurrence in Patients with Unprovoked Deep Vein Thrombosis or Pulmonary Embolism. 51st Annual Meeting of the American Society of Hematology, New Orleans, LA, 5\u20138 December 2009."},{"key":"key20160216115237868_ref1-bib37","unstructured":"Raskob GE, Anthonie LWA, Prins MH, Schellong S, Buller HR. Risk Assessment for Recurrent Venous Thromboembolism (VTE) After 6\u201314 Months of Anticoagulant Treatment. 23rd Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting, Kyoto, Japan, 23\u201328 July 2011."},{"key":"key20160216115237868_ref1-bib38","doi-asserted-by":"crossref","unstructured":"Tosetto A, Lorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, et al. Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score. 53rd Annual Meeting of the American Society of Hematology, San Diego, CA, 10\u201313 December 2011.","DOI":"10.1111\/j.1538-7836.2012.04735.x"},{"key":"key20160216115237868_ref1-bib39","unstructured":"Tosetto A, Lorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, et al. Clinical Prediction of VTE Recurrence in Patients with Previous Unprovoked Venous Thromboembolism. Results from an Individual-Level Meta-Analysis. 21st International Congress on Thrombosis \u2013 The Start of a New Era \u2013 Antithrombotic Agents, Milan, Italy 6\u20139 July 2010."},{"key":"key20160216115237868_ref1-bib40","unstructured":"Tosetto A, Lorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, et al. Clinical Prediction Guide to Predict Thrombosis Recurrence After a First Unprovoked Venous Thromboembolism. 22nd Congress of the International Society of Thrombosis and Haemostasis Boston, MA, 11\u201316 September 2009."},{"key":"key20160216115237868_ref1-bib41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib42","doi-asserted-by":"publisher","first-page":"e000467","DOI":"10.1161\/JAHA.113.000467","article-title":"D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model","volume":"3","author":"Eichinger","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"key20160216115237868_ref1-bib43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1586\/erc.11.62","article-title":"Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study)","volume":"9","author":"Romualdi","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"key20160216115237868_ref1-bib44","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1001\/archinte.1997.00440350022002","article-title":"A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy","volume":"157","author":"Douketis","year":"1997","journal-title":"Arch Intern Med"},{"key":"key20160216115237868_ref1-bib45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"key20160216115237868_ref1-bib46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/jnci\/86.11.829","article-title":"Dangers of using \u2018optimal\u2019 cutpoints in the evaluation of prognostic factors","volume":"86","author":"Altman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"key20160216115237868_ref1-bib47","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"key":"key20160216115237868_ref1-bib48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/9781420019940.002","article-title":"Prognostic models: a methodological framework and review of models for breast cancer","volume":"27","author":"Altman","journal-title":"Cancer Invest."},{"key":"key20160216115237868_ref1-bib49","doi-asserted-by":"crossref","DOI":"10.1002\/9780470770771","volume-title":"Multivariable Model-Building: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables","author":"Royston","year":"2008"},{"key":"key20160216115237868_ref1-bib50","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/sim.3148","article-title":"Selection of important variables and determination of functional form for continuous predictors in multivariable model building","volume":"26","author":"Sauerbrei","year":"2007","journal-title":"Stat Med"},{"key":"key20160216115237868_ref1-bib51","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"key20160216115237868_ref1-bib52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jclinepi.2012.12.017","article-title":"Individual participant data meta-analyses should not ignore clustering","volume":"66","author":"Abo-Zaid","year":"2013","journal-title":"J Clin Epidemiol."},{"key":"key20160216115237868_ref1-bib53","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0895-4356(96)00025-X","article-title":"Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis","volume":"49","author":"Sun","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"key20160216115237868_ref1-bib54","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jth.12871","article-title":"Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna prediction model using pooled individual patient data","volume":"13","author":"Marcucci","year":"2015","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2288-13-33","article-title":"External validation of a Cox prognostic model: principles and methods","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"key20160216115237868_ref1-bib56","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1002\/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2","article-title":"Validation, calibration, revision and combination of prognostic survival models","volume":"19","author":"van Houwelingen","year":"2000","journal-title":"Stat Med"},{"key":"key20160216115237868_ref1-bib57","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/01.CIR.0000079162.69615.0F","article-title":"Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia","volume":"108","author":"Palareti","year":"2003","journal-title":"Circulation"},{"key":"key20160216115237868_ref1-bib58","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1056\/NEJMoa054444","article-title":"D-dimer testing to determine the duration of anticoagulation therapy","volume":"355","author":"Palareti","year":"2006","journal-title":"N Engl J Med"},{"key":"key20160216115237868_ref1-bib59","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1538-7836.2008.02900.x","article-title":"Combination of D-dimer, F1\u2009+\u20092 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal","volume":"6","author":"Poli","year":"2008","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib60","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jama.290.8.1071","article-title":"D-dimer levels and risk of recurrent venous thromboembolism","volume":"290","author":"Eichinger","year":"2003","journal-title":"JAMA"},{"key":"key20160216115237868_ref1-bib61","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1538-7836.2008.02889.x","article-title":"Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors","volume":"6","author":"Baglin","year":"2008","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib62","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1538-7836.2006.01935.x","article-title":"D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism","volume":"4","author":"Shrivastava","year":"2006","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib63","first-page":"060","article-title":"Predicting risk of recurrent venous thrombosis using a 5-point scoring system including fibrin D-dimer","volume":"5","author":"Tait","year":"2007","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib64","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/sim.1691","article-title":"Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer","volume":"23","author":"Royston","year":"2004","journal-title":"Stat Med"},{"key":"key20160216115237868_ref1-bib65","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1002\/sim.5732","article-title":"A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis","volume":"32","author":"Debray","year":"2013","journal-title":"Stat Med"},{"key":"key20160216115237868_ref1-bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0037-1612936","article-title":"Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped","volume":"87","author":"Palareti","year":"2002","journal-title":"Thromb Haemost"},{"key":"key20160216115237868_ref1-bib67","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1111\/j.1538-7836.2006.02247.x","article-title":"Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes","volume":"4","author":"Cosmi","year":"2006","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib68","unstructured":"Cosmi B, Legnani C, Pengo V, Tosetto A, Ghirarduzzi A, Alatri A, et al. D-dimer and Sex as Risk Factors for Recurrence After a First Episode of Venous Thromboembolism in the Extended Follow-Up of the Prolong Study. 22nd Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, 11\u201316 July 2009."},{"key":"key20160216115237868_ref1-bib69","first-page":"246","article-title":"D-dimer can predict risk of recurrent venous thromboembolism regardless of patient age, timing of testing, or characteristics of assay","volume":"18","author":"Douketis","year":"2011","journal-title":"J Clin Outcomes Manag"},{"key":"key20160216115237868_ref1-bib70","unstructured":"Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, et al. D-dimer to Determine Risk for Disease Recurrence After Unprovoked Venous Thromboembolism: Addressing Unanswered Questions With a Large Individual Patient Meta-Analysis. 21st International Congress on Thrombosis \u2013 The Start of a New Era \u2013 Antithrombotic Agents, Milan, Italy 6\u20139 July 2010."},{"key":"key20160216115237868_ref1-bib71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"JR Stat Soc B Stat Methodol"},{"key":"key20160216115237868_ref1-bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0100100101","article-title":"Flexible parametric alternatives to the Cox model, and more","volume":"1","author":"Royston","year":"2001","journal-title":"Stata J"},{"key":"key20160216115237868_ref1-bib73","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional hazards and proportional odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"key20160216115237868_ref1-bib74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata Journal"},{"key":"key20160216115237868_ref1-bib75","volume-title":"Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model","author":"Royston","year":"2006"},{"key":"key20160216115237868_ref1-bib76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel inference understanding AIC and BIC in model selection","volume":"33","author":"Burnham","year":"2004","journal-title":"Sociol Methods Res"},{"key":"key20160216115237868_ref1-bib77","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"key20160216115237868_ref1-bib78","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"key20160216115237868_ref1-bib79","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"key":"key20160216115237868_ref1-bib80","doi-asserted-by":"crossref","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"Little","year":"2002","edition":"2nd edn."},{"key":"key20160216115237868_ref1-bib81","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for some traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"key20160216115237868_ref1-bib82","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"key":"key20160216115237868_ref1-bib83","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modelling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat Med"},{"key":"key20160216115237868_ref1-bib84","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2009"},{"key":"key20160216115237868_ref1-bib85","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/aje\/kwm341","article-title":"Comparison of methods of handling missing data in individual patient data meta-analyses: an empirical example on antibiotics in children with acute otitis media","volume":"167","author":"Koopman","year":"2008","journal-title":"Am J Epidemiol"},{"key":"key20160216115237868_ref1-bib86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"key20160216115237868_ref1-bib87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-14-5","article-title":"Assessing discriminative ability of risk models in clustered data","volume":"14","author":"van Klaveren","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"key20160216115237868_ref1-bib88","unstructured":"Douketis J, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, et al. Does the Clinical Presentation of Venous Thromboembolism Predict the Risk for and Type of Thrombosis Recurrence? 22nd Congress of the International Society of Thrombosis and Haemostasis, Boston, MA 11\u201316 July 2009."},{"key":"key20160216115237868_ref1-bib89","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1538-7836.2006.02291.x","article-title":"Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia","volume":"5","author":"Martinelli","year":"2007","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib90","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2165\/00019053-200624040-00006","article-title":"Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment","volume":"24","author":"Philips","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"key20160216115237868_ref1-bib91","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1111\/j.1538-7836.2012.04872.x","article-title":"Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study","volume":"10","author":"Chitsike","year":"2012","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib92","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/jth.12501","article-title":"Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis","volume":"12","author":"Castellucci","year":"2014","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib93","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"key":"key20160216115237868_ref1-bib94","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.107.726232","article-title":"Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry","volume":"117","author":"Laporte","year":"2008","journal-title":"Circulation"},{"key":"key20160216115237868_ref1-bib95","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1136\/jnnp.2004.055145","article-title":"Long term survival after primary intracerebral haemorrhage: a retrospective population based study","volume":"76","author":"Fogelholm","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20160216115237868_ref1-bib96","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2014","edition":"67th ed."},{"key":"key20160216115237868_ref1-bib97","volume-title":"Rivaroxaban for the Treatment of Deep Vein Thrombosis and Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism (NICE Technology Appraisal TA261)","author":"National Institute for Health and Care Excellence (NICE)","year":"2014"},{"key":"key20160216115237868_ref1-bib98","volume-title":"NHS Reference Costs 2012\u20132013","author":"Department of Health (DH)","year":"2013"},{"key":"key20160216115237868_ref1-bib99","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1161\/STROKEAHA.112.667204","article-title":"A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke","volume":"43","author":"Luengo-Fernandez","year":"2012","journal-title":"Stroke"},{"key":"key20160216115237868_ref1-bib100","volume-title":"Unit Costs of Health and Social Care 2013","author":"Personal Social Services Research Unit (PSSRU)","year":"2013"},{"key":"key20160216115237868_ref1-bib101","volume-title":"UK Population Norms for EQ-5D","author":"Kind","year":"1999"},{"key":"key20160216115237868_ref1-bib102","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","article-title":"The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life","volume":"156","author":"Gage","year":"1996","journal-title":"Arch Intern Med"},{"key":"key20160216115237868_ref1-bib103","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1160\/th04-02-0075","article-title":"Treatment of venous thromboembolism with vitamin K antagonists: patients\u2019 health state valuations and treatment preferences","volume":"92","author":"Locadia","year":"2004","journal-title":"Thromb Haemost"},{"key":"key20160216115237868_ref1-bib104","volume-title":"England and Wales Interim Life Tables 1980\u201382 and 2009\u201311.","author":"Office for National Statistics","year":"2012"},{"key":"key20160216115237868_ref1-bib105","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/bmj.39308.560069.BE","article-title":"NICE\u2019s cost effectiveness threshold","volume":"335","author":"Appleby","year":"2007","journal-title":"BMJ"},{"key":"key20160216115237868_ref1-bib106","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamainternmed.2013.563","article-title":"Estimating quality of life in acute venous thrombosis","volume":"173","author":"Hogg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"key20160216115237868_ref1-bib107","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/jamia.1997.0040049","article-title":"Automated computer interviews to elicit utilities: potential applications in the treatment of deep venous thrombosis","volume":"4","author":"Lenert","year":"1997","journal-title":"J Am Med Inform Assoc"},{"key":"key20160216115237868_ref1-bib108","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-0037-1613173","article-title":"Risk of deep vein thrombosis recurrence: high negative predictive value of D-dimer performed during oral anticoagulation","volume":"88","author":"Fattorini","year":"2002","journal-title":"Thromb Haemost"},{"key":"key20160216115237868_ref1-bib109","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","article-title":"Overweight, obesity, and the risk of recurrent venous thromboembolism","volume":"168","author":"Eichinger","year":"2008","journal-title":"Arch Intern Med"},{"key":"key20160216115237868_ref1-bib110","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"key20160216115237868_ref1-bib111","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1111\/j.1538-7836.2010.03991.x","article-title":"Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting","volume":"8","author":"Kearon","year":"2010","journal-title":"J Thromb Haemost"},{"key":"key20160216115237868_ref1-bib112","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harrell","year":"2001"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20120\/hta20120.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002388","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20120\/hta20120.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2003393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T12:06:57Z","timestamp":1718366817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta20120\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":112,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,2]]}},"alternative-id":["10.3310\/hta20120"],"URL":"https:\/\/doi.org\/10.3310\/hta20120","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}